Latest filing published 06 Nov 2026 for BeOne Medicines Ltd., €563k.
Insider track record
Titus Benjamin Ball: trading record in brief
Titus Benjamin Ball discloses dealings in BeOne Medicines Ltd. to SEC (Form 4). The record holds 3 filings, for trades running from 8 June 2026 to 6 November 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 6 November 2026, the filings show a transaction worth €563k in BeOne Medicines Ltd. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Titus Benjamin Ball
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,559 shares@ US$405.5659ADSSEC144:0001950047-26-010793
- 169 shares@ US$257.19860.0001% mcap54.0% of flowADSSEC144:0001950047-26-005933
- 136 shares@ US$271.32820.0001% mcap46.0% of flowADSSEC144:0001950047-26-005759
3 of 3 declarations
